Aspira Women's Health Inc. (AWHL): Gross Profit
$5.92M
Year ended 2025-12-31
$5.02M
Trailing 12 months to 2026-06-30
+11.0%
3-year compound annual growth
+36.8%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.92M | +8.0% | 2026-04-01, From 2025-01-01 |
| 2024-12-31 | $5.48M | +4.1% | 2026-04-01, From 2024-01-01 |
| 2023-12-31 | $5.26M | +21.7% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $4.32M | +41.2% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $3.06M | +147.7% | 2023-10-26, From 2021-01-01 |
| 2020-12-31 | $1.24M | +3.4% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $1.20M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$89.0K | n/m | 2020-04-07, From 2018-01-01 |
| 2017-12-31 | $207.0K | n/m | 2019-03-28, From 2017-01-01 |
| 2016-12-31 | -$56.0K | n/m | 2018-03-13, From 2016-01-01 |
| 2015-12-31 | -$132.0K | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | $1.29M | -46.1% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $2.40M | +22.1% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $1.96M | +9.4% | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | $1.79M | +65.0% | 2013-03-01, From 2011-01-01 |
| 2010-12-31 | $1.09M | n/a | 2012-03-27, From 2010-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $5.92M | +8.0% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $7.54M | +28.2% |
| Biomerica Inc (BMRA) | 2026-05-31 | $362.0K | -27.3% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $2.30M | +210.5% |
| Immucell Corp (ICCC) | 2025-12-31 | $11.45M | +44.1% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $13.44M | +85.9% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $1.34M | n/a |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $576.60M | -1.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $408.50M | -3.1% |
Compare AWHL, NNNN, BMRA, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗